Yoshihiro Kuroki

发表

Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer.

S. Hayes, Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, 2024, Clinical pharmacology and therapeutics.

Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial

Ö. Yalkinoglu, S. Gopalakrishnan, Karthik Venkatakrishnan, 2024, Clinical pharmacology and therapeutics.

Asia‐inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enabler

J. Bolleddula, N. Terranova, J. Mukker, 2024, Clinical and translational science.